Weill Cornell Medicine scientists target some of the most formidable health challenges of the 21st century, including cancer, cardiovascular disease, metabolic diseases, neurodegenerative diseases such as Parkinson’s and Alzheimer’s, diseases affecting children, and infectious diseases, especially those with significant impact on the developing world.
Dr. Robert Schwartz (Associate Professor of Medicine) was elected to the American Society for Clinical Investigation (ASCI). His groundbreaking work focuses on the clinical translation and research applications of stem cell-derived hepatocytes and primary human hepatocytes.
